Immunoassay with extended detection window
View Patent ↗The immunoassay method and kit are provided for the detection and/or the determination of zolpidem. The disclosure provides novel antibodies, derived from a novel immunogen, that are highly sensitive and bind to zolpidem and its main urinary metabolite [3-(2-N,N-dimethylamino-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid, enabling an extension of the detection window of zolpidem in individuals who have abused the drug, or have been victim of its side-effects or its criminal misuse.
1. A method of detecting or determining zolpidem and/or 4-[3-(2-N,N-dimethylamino-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid in a solution or an in vitro sample taken from a patient, comprising:
contacting the solution or sample with an antibody raised against an immunogen of the structure I:
wherein,
accm is an antigenicity conferring carrier material; n=0 or 1; X is a heteroatom; Y is a C 1-10 , substituted or unsubstituted straight-chain alkylene or arylene moiety; Z is, before conjugation with the accm, at least one of carboxy, a dithiopyridyl, a maleimide, an amino, a hydroxyl, a thiol, a thioester or an aldehyde moiety; and
a conjugate;
measuring a detectable signal generated from the conjugate upon binding of the antibody to zolpidem and/or 4-[3-(2-N,N-dimethylamino-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid and deducing the presence of or amount of zolpidem and/or 4-[3-(2-N,N-dimethylamino-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid in the sample, wherein the antibody has more than 5% cross-reactivity with 4-[3-(2-N,N-dimethylamino-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid based on 100% specificity to zolpidem.
2. The method as recited in claim 1 , wherein the heteroatom is one of nitrogen, oxygen or sulphur.
3. The method as recited in claim 1 , wherein Y is a C 2-6 .